← Back to Search

Behavioural Intervention

Education Program to Promote Cancer Screenings

N/A
Waitlist Available
Led By Poorna Kushalnagar
Research Sponsored by Gallaudet University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Self-reported diagnosis of bilateral hearing loss at birth or prior to 13 years old (defined as 'early deafness') and use ASL
Male or female at birth age 45-80 years old or female at birth age 45-80 years old; age-eligible according to screening criteria
Must not have
Not capable of independently conducting the activities of daily living
Presence of full ability to hear in one or both ears beyond 13 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to encourage cancer screenings for deaf, deafblind, and hard of hearing individuals who have not had screenings as per guidelines.

Who is the study for?
This trial is for deaf, deafblind, and hard of hearing individuals who have not been screened for cancer as recommended. Specific eligibility criteria are not provided.
What is being tested?
The trial is testing an educational program designed to encourage cancer screenings among the DDBHH community.
What are the potential side effects?
Since this intervention involves education rather than medication or medical procedures, there are no direct physical side effects expected from participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was diagnosed with hearing loss before I turned 13 and I use American Sign Language.
Select...
I am between 45 and 80 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I need help with my daily activities.
Select...
I have had normal hearing in at least one ear since I was 13.
Select...
I am currently receiving cancer treatment or being evaluated for cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of participants who are adherent to cancer screening
Secondary study objectives
Percent of participants who demonstrate high cancer knowledge and high perceived patient centered care

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
CHN provides educational sessions with patients at time points.
Group II: Standard of CareActive Control1 Intervention
Standard of care to inform participant about the screening recommendations and check ins.

Find a Location

Who is running the clinical trial?

Gallaudet UniversityLead Sponsor
2 Previous Clinical Trials
50 Total Patients Enrolled
2 Trials studying Deafness
50 Patients Enrolled for Deafness
Poorna KushalnagarPrincipal InvestigatorGallaudet University
~92 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top